ES519056A0 - Un procedimiento para la preparacion de hexahidroindazolo o hexahidroisoindolo-isoquinolinas 6-sustituidas. - Google Patents

Un procedimiento para la preparacion de hexahidroindazolo o hexahidroisoindolo-isoquinolinas 6-sustituidas.

Info

Publication number
ES519056A0
ES519056A0 ES519056A ES519056A ES519056A0 ES 519056 A0 ES519056 A0 ES 519056A0 ES 519056 A ES519056 A ES 519056A ES 519056 A ES519056 A ES 519056A ES 519056 A0 ES519056 A0 ES 519056A0
Authority
ES
Spain
Prior art keywords
preparation
substituted
isoquinolinas
hexahidroisoindolo
hexahidroindazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES519056A
Other languages
English (en)
Other versions
ES8403459A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES519056A0 publication Critical patent/ES519056A0/es
Publication of ES8403459A1 publication Critical patent/ES8403459A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/14Aza-phenalenes, e.g. 1,8-naphthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES519056A 1981-03-24 1983-01-17 Un procedimiento para la preparacion de hexahidroindazolo o hexahidroisoindolo-isoquinolinas 6-sustituidas. Expired ES8403459A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24704781A 1981-03-24 1981-03-24

Publications (2)

Publication Number Publication Date
ES519056A0 true ES519056A0 (es) 1984-03-16
ES8403459A1 ES8403459A1 (es) 1984-03-16

Family

ID=22933334

Family Applications (2)

Application Number Title Priority Date Filing Date
ES510695A Expired ES8305762A1 (es) 1981-03-24 1982-03-23 Un procedimiento para la preparacion de hexahidroindazolo o hexahidroisoindolo-isoquinolinas 6-sustituidas.
ES519056A Expired ES8403459A1 (es) 1981-03-24 1983-01-17 Un procedimiento para la preparacion de hexahidroindazolo o hexahidroisoindolo-isoquinolinas 6-sustituidas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES510695A Expired ES8305762A1 (es) 1981-03-24 1982-03-23 Un procedimiento para la preparacion de hexahidroindazolo o hexahidroisoindolo-isoquinolinas 6-sustituidas.

Country Status (21)

Country Link
EP (2) EP0061341B1 (es)
JP (1) JPS57171993A (es)
KR (1) KR830009098A (es)
AT (2) ATE33641T1 (es)
AU (1) AU8181482A (es)
CA (3) CA1182457A (es)
DD (1) DD202161A5 (es)
DE (2) DE3278359D1 (es)
DK (1) DK130282A (es)
ES (2) ES8305762A1 (es)
FI (1) FI820938L (es)
GB (2) GB2095255B (es)
GR (1) GR75926B (es)
HU (1) HU189572B (es)
IL (3) IL65269A0 (es)
PH (2) PH18370A (es)
PL (2) PL235582A1 (es)
PT (1) PT74612B (es)
RO (2) RO86517B (es)
SU (1) SU1189349A3 (es)
ZA (1) ZA821805B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3624607A1 (de) * 1986-07-21 1988-01-28 Boehringer Ingelheim Kg Neue tetrahydrobenzothiazolo-chinoline ihre herstellung und verwendung
CN107434781A (zh) * 2016-05-27 2017-12-05 河南工业大学 一种1-烯基-异喹啉衍生物的制备方法及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198415A (en) * 1979-01-22 1980-04-15 Eli Lilly And Company Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines
DK268979A (da) * 1979-01-22 1980-07-23 Lilly Co Eli Fremgangsmaade til fremstilling af octahydro-2h-pyrrolo (3,4-g)quinoliner
US4201862A (en) * 1979-03-16 1980-05-06 Eli Lilly And Company 2-Azaergolines and 2-aza-8(or 9)-ergolenes

Also Published As

Publication number Publication date
ATE33641T1 (de) 1988-05-15
FI820938L (fi) 1982-09-25
SU1189349A3 (ru) 1985-10-30
EP0151319B1 (en) 1988-04-20
CA1182457A (en) 1985-02-12
EP0061341A2 (en) 1982-09-29
IL74836A0 (en) 1985-07-31
IL74837A0 (en) 1985-07-31
GB2095255A (en) 1982-09-29
EP0151319A1 (en) 1985-08-14
RO82502B (ro) 1983-08-30
ES510695A0 (es) 1983-04-16
AU8181482A (en) 1982-09-30
DE3270838D1 (en) 1986-06-05
EP0061341B1 (en) 1986-04-30
GB8425095D0 (en) 1984-11-07
DE3278359D1 (en) 1988-05-26
EP0061341A3 (en) 1982-12-08
RO86517A (ro) 1985-03-15
CA1187883A (en) 1985-05-28
GB2095255B (en) 1985-07-17
ES8403459A1 (es) 1984-03-16
ZA821805B (en) 1983-10-26
JPS57171993A (en) 1982-10-22
IL65269A0 (en) 1982-05-31
DD202161A5 (de) 1983-08-31
DK130282A (da) 1982-09-25
RO82502A (ro) 1983-09-26
PL235582A1 (en) 1983-08-15
KR830009098A (ko) 1983-12-17
ES8305762A1 (es) 1983-04-16
PH18370A (en) 1985-06-13
ATE19517T1 (de) 1986-05-15
CA1187884A (en) 1985-05-28
HU189572B (en) 1986-07-28
PT74612B (en) 1984-11-27
PH18719A (en) 1985-09-11
RO86517B (ro) 1985-03-30
PT74612A (en) 1982-04-01
GR75926B (es) 1984-08-02
PL240285A1 (en) 1983-09-12

Similar Documents

Publication Publication Date Title
ES545700A0 (es) Procedimiento para preparar derivados de acidos 11-sustitui-dos-16-fenoxi y 16-fenoxi sustituido-prostatrienoicos
FI872555A (fi) Antiallergiska och antiinflammatoriska aemnen.
ES510695A0 (es) Un procedimiento para la preparacion de hexahidroindazolo o hexahidroisoindolo-isoquinolinas 6-sustituidas.
PT88256A (pt) Processo para a preparacao de agentes antiarritmicos de 1,2,3,4-tetra-hidroisoquinolina
NO903514D0 (no) Imidazolderivat og fremgangsmaate til dets fremstilling.
ES8106144A1 (es) Procedimiento para la preparacion de derivados de aroilete- nilpiperidinobutirofenona
ES8106143A1 (es) Procedimiento para la preparacion de derivados de cinamoil- piperidinobutirofenona
ATE53833T1 (de) Derivate des phenylacetanilids.
DE3874982D1 (de) Antipsychotische zusammensetzungen mit dioxopiperidin-derivaten.
JPS53121769A (en) Preparation of novel quinoline derivatives
EP0138223A3 (en) Thiazine derivatives, processes for preparation thereof and pharmaceutical conmposition comprising the same